Search

Leon H Zalkow

age ~95

from Atlanta, GA

Get Report
Also known as:
  • Leon Harry Zalkow
  • Leon H Lalko
Phone and address:
170 Zeblin Rd, Atlanta, GA 30342
404 256-1540
Related to:
Connected to:

Leon Zalkow Phones & Addresses

  • 170 Zeblin Rd, Atlanta, GA 30342 • 404 256-1540 • 404 843-2226
  • Sandy Springs, GA
  • 1130 NW 12Th Ave APT 312, Portland, OR 97209
  • 2615 Pisgah Forest Dr, Pisgah Forest, NC 28768 • 828 884-4704
  • Hoschton, GA
  • 170 Zeblin Rd NE, Sandy Springs, GA 30342 • 678 576-5008

Work

  • Position:
    Retired

Education

  • Degree:
    High school graduate or higher

Emails

y***[email protected]

Us Patents

  • Method Of Treating Cancers Sensitive To Treatment With Water Soluble Derivatives Of Taxol

    view source
  • US Patent:
    51570491, Oct 20, 1992
  • Filed:
    Oct 31, 1991
  • Appl. No.:
    7/784624
  • Inventors:
    Rudiger D. Haugwitz - Bethesda MD
    Leon Zalkow - Atlanta GA
    Jan Glinski - Ridgefield CT
    Mathew Suffness - Silver Spring MD
    Howard M. Deutsch - Atlanta GA
    Venkatachala Narayanan - Gaithersburg MD
  • Assignee:
    The United States of America as represented by the Department of Health
    & Human Services - Washington DC
  • International Classification:
    A61K 31335
    A61K 3154
    A61K 31535
    A61K 31495
    A61K 31445
    A61K 3140
  • US Classification:
    514449
  • Abstract:
    The invention involves the treatment of cancer in humans by administering water soluble derivatives of taxol. The types of cancer so treatable are those sensitive to treatment with taxol.

  • Substituted N-Methyl Derivatives Of Mitindomide

    view source
  • US Patent:
    48032026, Feb 7, 1989
  • Filed:
    Mar 12, 1987
  • Appl. No.:
    7/025062
  • Inventors:
    Rudiger D. Haugwitz - Bethesda MD
    Leon H. Zalkow - Atlanta GA
    Howard M. Deutsch - Atlanta GA
    Leslie Gelbaum - Atlanta GA
  • Assignee:
    The United States of America as represented by the Secretary of the
    Department of Health and Human Services - Washington DC
  • International Classification:
    A61K 3138
    A61K 3140
    C07D20956
  • US Classification:
    5142282
  • Abstract:
    New substituted N-methyl derivatives of mitindomide and methods of preparing the same are disclosed. The novel compounds are water soluble and have anti-neoplastic activity.

  • Seco-Cholestane Derivatives And Methods Of Making The Same

    view source
  • US Patent:
    60110589, Jan 4, 2000
  • Filed:
    Sep 22, 1998
  • Appl. No.:
    9/158656
  • Inventors:
    Leon H. Zalkow - Atlanta GA
    Hairuo Peng - Atlanta GA
  • Assignee:
    Georgia Tech Research Corporation - Atlanta GA
  • International Classification:
    A61K 31335
    C07D31306
  • US Classification:
    514462
  • Abstract:
    The present invention is directed to novel seco-cholestane derivatives, as well as to pharmaceutical compositions thereof, and methods of making the same. More particularly, the invention relates to C5- and C8-substituted seco-cholestane derivatives. The compounds of the invention can exhibit CDC25 phosphatase inhibition properties and anti-cancer activity.

  • Formaldehyde Derivatives Of Mitindomide

    view source
  • US Patent:
    46704612, Jun 2, 1987
  • Filed:
    Apr 26, 1984
  • Appl. No.:
    6/604136
  • Inventors:
    Rudiger D. Haugwitz - Bethesda MD
    Venkatachala L. Narayanan - Gaithersburg MD
    Leon H. Zalkow - Atlanta GA
    Howard M. Deutsch - Atlanta GA
  • Assignee:
    The United States of America as represented by the Department of Health
    and Human Services - Washington DC
  • International Classification:
    C07D20956
    A61K 3140
  • US Classification:
    514410
  • Abstract:
    New substituted, formaldehyde derived mitindomide and methods of preparing the same are disclosed. The novel compounds are water soluble and have anti-neoplastic activity. The formaldehyde derived mitindomide is prepared by reacting mitindomide with formaldehyde and further acetylating the derived hydroxymethyl compound. The amido compounds can be derived by reacting mitindomide in mannich fashion, i. e-formaldehyde and secondary amines.

  • Aroylaniline Compounds, Pharmaceutical Compositions, And Methods Of Using Same To Inhibit Viral Activity

    view source
  • US Patent:
    56818327, Oct 28, 1997
  • Filed:
    Feb 17, 1995
  • Appl. No.:
    8/390057
  • Inventors:
    Rudiger D. Haugwitz - Bethesda MD
    Leon Zalkow - Atlanta GA
    Edward Burgess - Marietta GA
  • Assignee:
    The United States of America as represented by the Department of Health
    and Human Services - Washington DC
    Georgia Tech Research Corporation - Atlanta GA
  • International Classification:
    A61K 31655
    C07D21516
    C07D21520
  • US Classification:
    514150
  • Abstract:
    Aroylaniline compounds which exhibit anti-retroviral activity, pharmaceutical compositions containing such aroylaniline compounds, and methods for treating a retroviral-infected host comprising administering an antiviral effective amount of an aroylaniline compound to a host.

  • Water Soluble, Antineoplastic Derivatives Of Taxol

    view source
  • US Patent:
    49421840, Jul 17, 1990
  • Filed:
    Mar 7, 1988
  • Appl. No.:
    7/165173
  • Inventors:
    Rudiger D. Haugwitz - Bethesda MD
    Leon Zalkow - Atlanta GA
    Jan Glinski - Ridgefield CT
    Mathew Suffness - Silver Spring MD
    Howard M. Deutsch - Atlanta GA
    Venkatachala Narayanan - Gaithersburg MD
  • Assignee:
    The United States of America as represented by the Department of Health
    and Human Services - Washington DC
  • International Classification:
    A61K 31335
    C07D30514
  • US Classification:
    514449
  • Abstract:
    Antineoplastic, water soluble, taxol derivatives and methods for preparing the same are described.
Get Report for Leon H Zalkow from Atlanta, GA, age ~95
Control profile